Intellectual Property and Antitrust
Show Less

Intellectual Property and Antitrust

A Comparative Economic Analysis of US and EU Law

Mariateresa Maggiolino

This insightful book compares how the US and EU antitrust authorities have enforced Section 2 of the Sherman Act, and Article 102 of the TFEU against monopolists' practices involving intellectual property rights.
Show Summary Details
You do not have access to this content

Chapter 6: IP Judicial and Administrative Processes

Mariateresa Maggiolino


IP AND ANTITRUST APPROACHES TO INFRINGEMENT ACTIONS AND SOME IP ADMINISTRATIVE PROCEDURES IPR ownership may give access to some otherwise inaccessible ‘legal devices’ whose existence is intrinsically connected to the architecture of IP regimes. For instance, since IPRs are exclusive rights, their holders can bring specific legal actions, named ‘infringement actions’, against those who embezzle their inventions and creative works.1 Analogously, in the highly regulated pharmaceutical industry the mere ownership of a patent may involve some specific administrative procedures – such as the procurement of a supplementary protection certificate (hereinafter, ‘SPC’)2 and the listing of a patented drug in the Orange Book3 – that IP legislators created in order to govern product entrance into that industry.4 1 Since the beginning of the XX century the US Supreme Court wrote that, ‘the heart of [a patentee’s] legal monopoly is the right to invoke the State’s power to prevent others from utilizing his discovery without his consent’ – see Crown Die & Tool Co. v. Nye Tool & Machine Works, 261 U.S. 24, 43 (1923). See, further, Wesley M. Cohen, Richard R. Nelson, John P. Walsh, ‘Protecting their Intellectual Assets: Appropriability conditions and why U.S. Manufacturing firms patent (or not)’ 25 (2000), available at w7552 (showing that, ‘the threat, often implicit, of infringement suits and countersuits underpins almost all the uses of patents, whether to force participation in cross-licensing negotiations in complex product industries, to build patent fences in discrete product industries, or to protect the ability to license or commercialize a new...

You are not authenticated to view the full text of this chapter or article.

Elgaronline requires a subscription or purchase to access the full text of books or journals. Please login through your library system or with your personal username and password on the homepage.

Non-subscribers can freely search the site, view abstracts/ extracts and download selected front matter and introductory chapters for personal use.

Your library may not have purchased all subject areas. If you are authenticated and think you should have access to this title, please contact your librarian.

Further information

or login to access all content.